TNFRSF21/DR6 Monoklonaler Antikörper

TNFRSF21/DR6 Monoklonal Antikörper für WB, IF/ICC, Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human

Anwendung

WB, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

3C2D10

Kat-Nr. : 66754-1-PBS

Synonyme

DR6, TNFRSF21, 3C2D10, CD358, Death receptor 6



Geprüfte Anwendungen

Produktinformation

66754-1-PBS bindet in WB, IF/ICC, Indirect ELISA TNFRSF21/DR6 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen TNFRSF21/DR6 fusion protein Ag14327
Vollständiger Name tumor necrosis factor receptor superfamily, member 21
Berechnetes Molekulargewicht 655 aa, 72 kDa
Beobachtetes Molekulargewicht 69 kDa
GenBank-ZugangsnummerBC021572
Gene symbol DR6
Gene ID (NCBI) 27242
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

TNFRSF21 (also known as DR6 or CD358) is an orphan receptor of the tumor necrosis factor (TNF) receptor superfamily. It controls cell death and differentiation in a cell-autonomous manner in different cell types including neurons, oligodendrocytes, endothelial cells, and immune cells (PMID: 29459438). DR6 has been shown to activate NF-κB and JNK, and induce cell apoptosis (PMID: 9714541). DR6 interacts with TRADD, which is known to mediate signal transduction of TNF receptors. It has been reported that APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, indicating that DR6 might be involved in Alzheimer's disease (PMID: 19225519).